Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
958 results about "Urinary incontinence" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Involuntary loss of large or small amounts of urine.
External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
An external stimulator adapted to be inductively coupled with an implanted lead-receiver is designed to deliver neuromodulation therapy for disorders including depression, migraine, partial complex epilepsy, generalized epilepsy, involuntary movement disorders, dementia, obsessive compulsive disorders, urinary incontinence, neurogenic / psychogenic pain and bladder control. The external stimulator containing limited number of predetermined programs packaged into the stimulator, giving the patient or caretaker a way to adjust the therapy within confined limits, or turn the device off. The pre-packaged programs contain unique combination of pulse amplitude, pulse width, frequency of stimulation, and on-off time. The programs are capable of being modified with a programming station connected to the pulse generator with a RS232-C serial connection.
Owner:NEURO & CARDIAC TECH
Implantable article and method for treating urinary incontinence using means for repositioning the implantable article
InactiveUS6652450B2Adversely therapeutic effectPrevent permanent deformationSuture equipmentsIncision instrumentsDiseaseUrological Disorders
Owner:STASKIN DAVID MD DR
Treatment of urinary incontinence and other disorders by application of energy and drugs
Owner:VERATHON
Protective sheath for transvaginal anchor implantation devices
Bone anchor implantation devices and methods for their use are disclosed. The bone anchor implantation devices and methods find particular application in maintaining or improving urinary continence by suspending or stabilizing the bladder neck. Protective sheaths for covering a bone anchor on a bone anchor implantation device are disclosed. The protective sheaths protect the bone anchor from contacting tissue during insertion and prevent contamination of the bone anchor.
Owner:BOSTON SCI SCIMED INC
Method and apparatus for correction for gynecological pathologies including treatment of female cystocele
Owner:BOSTON SCI SCIMED INC
Coated sling material
InactiveUS7025063B2Minimize complexityGood biocompatibilitySuture equipmentsAnti-incontinence devicesUrethraShort urethra
The present invention relates to a sling, methods of making and using a sling, and kits comprising a sling for treating urinary incontinence. The sling has multiple elongation properties that serve to improve the support of the urethra. The sling may comprise a coated material adapted for urethral suspension. The coated sling has properties that appear to enhance the sling elongation characteristics. The coated sling further includes properties that reduce its susceptibility to bacterial infections. The sling further includes properties to enhance the proper tensioning of the sling.
Owner:BOSTON SCI SCIMED INC
Muscarinic receptor antagonists
Disclosed are multibinding compounds which are muscarinic receptor antagonists. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is, independently of each other, a muscarinic receptor antagonist or an allosteric modulator provided that at least one of said ligand is a muscarinic receptor antagonist. The multibinding compounds of this invention are useful in the treatment and prevention of diseases such as chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, urinary incontinence, and the like.
Owner:THERAVANCE BIOPHARMA R&D IP LLC
Surgical instrument and method for treating female urinary incontinence
InactiveUS20020128670A1Reduces risk of perforationReduce riskSuture equipmentsAnti-incontinence devicesUrethraVaginal walls
The invention relates to a surgical instrument and a method for treating female urinary incontinence. A tape or mesh is permanently implanted into the body as a support for the urethra. In one embodiment, portions of the tape comprise tissue growth factors and adhesive bonding means for attaching portions of the tape to the pubic bone. In a further embodiment, portions of the tape comprise attachment means for fastening portions of the tape to fascia within the pelvic cavity. In both embodiments the tape is implanted with a single incision through the vaginal wall.
Owner:ULMSTEN ULF +1
Incontinence sling
A sling for controlling urinary incontinence is disclosed. The sling is formed from a tube having substantially lengthwise inextensible end portions and an elastically lengthwise extensible intermediate portion between the end portions. The intermediate portion has a U-shape which cradles the urethra. The end portions extend through the abdominal tissue to anchor the intermediate portion in position. The sling places the urethra under a transverse compressive load to hold it closed and prevent inadvertent urination. The tube is formed from interlaced filamentary members. Interlacing may be by warp knitting, weaving using a leno weave or braiding using a tri-axial braid structure. The end portions have a rough texture to facilitate anchoring in the tissue of the abdominal wall. The intermediate portion is smooth and soft to prevent tissue erosion.
Owner:STOUT MEDICAL GROUP
Methods and devices for treating urinary incontinence
Described herein are devices, systems and methods for treatment of tissue within a lumen of a body. For example, the devices described herein may be used to treat the urethra or gastrointestinal tract, including a sphincter. These devices may provide an expandable element at the distal end of an elongate body and may also include a plurality of electrodes (e.g., needle electrodes) configured to extend from the device and into the tissue to deliver energy to multiple, circumferentially arranged treatment sites. Sufficient energy may be delivered from the device to create a desired tissue effect.
Owner:VERATHON
Magnetic nerve stimulation seat device
A magnetic nerve stimulator system is comprised of a core constructed from a material having a high field saturation with a coil winding. A thyrister capacitive discharge circuit pulses the device. A rapidly changing magnetic field is guided by the core, preferably vanadium permendur. For task specific excitation of various nerve groups, specially constructed cores allow for excitation of nerves at deeper levels with higher efficiency than is possible with air-core stimulators. Among the applications possible with this invention are treatment of incontinence, rehabilitation of large muscle groups in the leg and arm, and excitation of abdominal wall muscle groups to aid in weight loss and metabolic rate increase. A C-shape is employed for focussing the stimulation as desired.
Owner:MAGIC RACE
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
ActiveUS20050025755A1Rapid and reliableHigh yieldBiocideElectrotherapyBreast augmentationAutologous Fat Transfer
Methods of treating patients for conditions such as breast augmentation, soft tissue defects, and urinary incontinence, are described. The methods include removing adipose tissue from a patient, processing a portion of the adipose tissue to obtain a substantially isolated population of regenerative cells, mixing the regenerative cells with another portion of adipose tissue to form a composition, and administering the composition to the patient from which the adipose tissue was removed.
Owner:LOREM VASCULAR PTE LTD
Noninvasive devices, methods, and systems for shrinking of tissues
InactiveUS20100049186A1Sufficient energyPrevent shrinkageUltrasound therapyDiagnosticsUrethraNon invasive
The invention provides improved methods for modifying collagenous tissues, particularly for treating urinary incontinence in a noninvasive manner. The methods typically include inserting a probe into a patient's urethra, transmitting electromagnetic energy from the probe to a collagneous target tissue, and cooling the tissue in the vicinity of the probe. The probe may include an expandable element at or near the distal end that is configured to expand within the patient's bladder. The expandable element may anchor the probe before or during treatment.
Owner:BOSTON SCI SCIMED INC +1
Apparatus and method for treating female urinary incontinence
InactiveUS20060205995A1Reduce rejectionEasy to manufactureSuture equipmentsAnti-incontinence devicesUrethraVagina
The present invention provides a surgical implant and method for supporting the urethra where the implant includes a suburethral support suspended between two soft tissue anchors. The surgical implant is introduced into at least one incision made on the upper wall of a vagina with the first soft tissue anchor inserted on a first side of the urethra behind the pubic bone, and the second soft tissue anchor inserted on a second side of the urethra behind the pubic bone, such that the suburethral support is suspended from the soft tissue anchors and supports the urethra. Each of the first and second soft tissue anchors are inserted in, and fix in, the soft tissue of the perineum without penetrating the obturator foramen.
Owner:COLOPLAST AS
Minimally invasive medical implant and insertion device and method for using the same
ActiveUS20060025649A1Anti-incontinence devicesSurgical needlesStress incontinenceBiomedical engineering
A medical implant and method for implantation of the same. One embodiment is an implant for use in the treatment of stress urinary incontinence that includes an implantable, elongated tape having a multiplicity of openings formed through the thickness thereof, the tape having a first end region and a second end region longitudinally opposite the first end region, and first and second bio-compatible fixation elements attached to the first and second end regions of the tape respectively. Each bio-compatible fixation element has a tissue adherence property greater than that of the tape.
Owner:ETHICON INC
Prosthetic implant for sub-urethral support, an instrument, an insertion kit, and a surgical method for implanting it
InactiveUS20050277806A1Reduce riskSurgery to be simpleAnti-incontinence devicesSurgeryUrethraProsthesis
The invention provides a prosthetic implant for supporting the urethra, the implant comprising a flexible elongate element and being provided: with a central portion for being positioned beneath the urethra when the elongate element is in its functional position in the body; and two ends situated on either side of the central portion; wherein said ends are positioned relative to the central portion in such a manner that when the elongate element is in the functional position, one of the ends of the elongate element is disposed between the right internal obturator muscle and the right external obturator muscle, while the other end is disposed between the left internal obturator muscle and the left external obturator muscle. The prosthetic implant is suitable for correcting urinary incontinence.
Owner:CIE DE RECH & COMPOSANTS IMPLANTS & MATERIELS POUR LAPPL CLINIQUE
Surgical method for treating urinary incontinence, and apparatus for use in same
A surgical method for treating urinary incontinence by securing a suture within a patient's body, retrieving a portion of the suture into the patient's vagina, and supporting the patient's urethra using the suture. A surgical method for elevating a patient's urethra in order to treat urinary incontinence, a surgical method for securing an anchor in a patient, a helical anchor and an anchor-insertion tool are also provided.
Owner:DEXTERITY SURGICAL
Surgical procedure for the treatment of female urinary incontinence: tension-free inside-out transobturator urethral suspension
A new, quick, simple, efficient, safe, and reproducible surgical technique for the treatment of female urinary incontinence, in which the posterior urethra is suspended using a tape passed through the obturator orifices from inside (underneath the urethra) to outside (thigh folds). A variety of specifically designed surgical instruments are utilized to perform this operative procedure.
Owner:UNIV LIEGE +1
Method and system for modulating sacral nerves and/or its branches in a patient to provide therapy for urological disorders and/or fecal incontinence, using rectangular and/or complex electrical pulses
A method and system for providing pulsed electrical stimulation to sacral nerves and / or its branches, to provide therapy for urinary / fecal incontinence and other urological disorders. The stimulation system comprising implanted and external components. The pulsed electrical stimulation may be provided using a system which is one from a group comprising: a) an implanted stimulus-receiver with an external stimulator; b) an implanted stimulus-receiver comprising a high value capacitor for storing charge, used in conjunction with an external stimulator; c) a programmer-less implantable pulse generator (IPG) which is operable with an external magnet; d) a programmable implantable pulse generator; e) a combination implantable device comprising both a stimulus-receiver and a programmable IPG; and f) an implantable pulse generator (IPG) comprising a rechargeable battery. In one embodiment, the external components such as the programmer or external stimulator may comprise telemetry means for interrogation or programming of the implanted device from a remote location, over a wide area network.
Owner:BOVEJA BIRINDER R +1
Mesh implant
A mesh implant is disclosed which may be utilized for treating urinary incontinence, hernias, uterovaginal prolapses and other related injuries.
Owner:TYCO HEALTHCARE GRP LP
Surgical instrument and method for treating female urinary incontinence
The invention relates to a surgical instrument and a method for treating female urinary incontinence. A tape or mesh is permanently implanted into the body as a support for the urethra. In one embodiment, portions of the tape comprise tissue growth factors and adhesive bonding means for attaching portions of the tape to the pubic bone. In a further embodiment, portions of the tape comprise attachment means for fastening portions of the tape to fascia within the pelvic cavity. In both embodiments the tape is implanted with a single incision through the vaginal wall.
Owner:ETHICON INC
Injectable microspheres for dermal augmentation and tissue bulking
The present invention relates to elastic, hydrophilic and substantially spherical microspheres useful for dermal augmentation and tissue bulking. The invention provides injectable compositions comprising the microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further provides methods of dermal augmentation and tissue bulking, particularly for the treatment of skin contour deficiencies, Gastro-esophageal reflux disease, urinary incontinence, and urinary reflux disease, using the injectable compositions.
Owner:BIOSPHERE MEDICAL INC
Surgical procedure for the treatment of female urinary incontinence: tension-free inside-out transobturator urethral suspension
Owner:UNIV LIEGE +1
Intraurethral pressure monitoring assembly and method of treating incontinence using same
A method of treating urinary incontinence in a patient by: providing a pressure monitor probe comprising a catheter having a pressure responsive region and a distal portion, the pressure responsive region spaced a predetermined distance from the distal portion; inserting the pressure monitor probe into the patient's urethra such that the distal portion is positioned in the patient's bladder adjacent the UVJ, thereby positioning the pressure responsive region of the catheter within the urethra a predetermined distance from the UVJ; and surgically modifying the pressure applied against the urethra while monitoring the pressure applied against the urethra using the probe. An intraurethral pressure monitor probe and an intraurethral pressure monitoring assembly are also provided.
Owner:DEXTERITY SURGICAL
Treatment of urinary incontinence and other disorders by application of energy and drugs
The invention provides a method and system for treating disorders in parts of the body. A particular treatment can include on or more of, or some combination of: ablation, nerve modulation, three-dimensional tissue shaping, drug delivery, mapping stimulating, shrinking and reducing strain on structures by altering the geometry thereof and providing bulk to particularly defined regions. The particular body structures or tissues can include one or more of or some combination of region, including: the bladder, esophagus, vagina, penis, larynx, pharynx, aortic arch, abdominal aorta, thoracic, aorta, large intestine, sinus, auditory canal, uterus, vas deferens, trachea, and all associated sphincters. Types of energy that can be applied include radiofrequency, laser, microwave, infrared waves, ultrasound, or some combination thereof. Types of substances that can be applied include pharmaceutical agents such as analgesics, antibiotics, and anti-inflammatory drugs, bulking agents such as biologically non-reactive particles, cooling fluids, or dessicants such as liquid nitrogen for use in cryo-based treatments.
Owner:VERATHON
Surgical Grafts
InactiveUS20080125869A1Anti-incontinence devicesSurgical staplesAnterior vaginal wall prolapseSurgical Graft
Provided is a surgical graft having one or more pockets adapted to receive a shaft tip of a surgical fastening device. The graft of the invention may be made from a biodegradable material, a biological material, a non-biodegradable material, biodegradable material, or a combination of any of these. The graft may be of a mesh construction, and may have an elongated shape, or may be shaped as a patch. The graft may be used, for example, in a method for treating urinary incontinence, vaginal vault repair, posterior vaginal wall prolapse, anterior vaginal wall prolapse and inguinal hernia. The invention also provides a system including a surgical graft of the invention, one or more surgical fasteners, and a surgical fastening device having a shaft and configured to eject at least one of the surgical fasteners from the tip of the shaft.
Owner:ENDOGUN MEDICAL SYST
Evaluating patient incontinence
ActiveUS20080300449A1ElectrotherapyUrological function evaluationPhysical therapyPatients activity level
Systems and methods for determining a number of interruptions in a sleep state of a patient attributable to an urge or need to void during a sleep event include monitoring an activity level of the patient. The urge or need to void may be attributable to fecal or urinary incontinence. The patient activity level may be determined with one or more sensors that detect motion and / or one or more sensors that monitor a physiological parameter of the patient that varies as a function of patient activity. In one embodiment, a clinician selects a therapy parameter set for the patient based on the severity of the patient's incontinence. In another embodiment, the number of interruptions in the sleep state is associated with a therapy parameter set that was implemented during the sleep state in order to evaluate the efficacy of the therapy parameter set. In another embodiment, a medical device automatically adjusts a therapy parameter to treat the incontinence if the number of interruptions in the sleep state exceeds a threshold.
Owner:MEDTRONIC INC
Apparatuses for the Amelioration of Urinary Incontinence in Females
ActiveUS20080281149A1Minimized in sizeSmall sizeDispensing apparatusDiagnosticsUrinary incontinenceUrethra
An apparatus for treating urinary incontinence, comprising: a support section adapted for providing urethral support; an anchoring section for resisting movement of the apparatus; an insert, a portion of which is adapted to be positioned where the support section attaches to the node; and, wherein the insert urges the support section radially outwards from a central axis of the apparatus.
Owner:KIMBERLY-CLARK WORLDWIDE INC
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
ActiveUS7651684B2Diminished and non-existent needRapid and reliable deviceBiocideElectrotherapyAutologous Fat TransferBreast augmentation
Methods of treating patients for conditions such as breast augmentation, soft tissue defects, and urinary incontinence, are described. The methods include removing adipose tissue from a patient, processing a portion of the adipose tissue to obtain a substantially isolated population of regenerative cells, mixing the regenerative cells with another portion of adipose tissue to form a composition, and administering the composition to the patient from which the adipose tissue was removed.
Owner:LOREM VASCULAR PTE LTD
Devices and methods for treatment of incontinence
InactiveUS6964643B2Increase blood flowPrevent involuntary contractionPneumatic massageDiagnosticsGenital regionGynecology
Therapeutic devices and methods according to embodiments of the invention alleviate e.g. urinary incontinence in female and male patients. Suction or vacuum, for example, is applied to the genital region, clitoris or clitoral region, the external urethral orifice, and / or other designated areas, e.g. physically stimulating the sacral / pudendal nerves and / or nerve roots and alleviating incontinence. Such embodiments also can encourage or cause clitoral engorgement, or otherwise promote blood flow in the genital region. Vacuum or suction applied to e.g. the clitoris creates a negative pressure in the clitoris that is lower than the systolic blood pressure, tending to promote engorgement of the clitoris with blood. Aspects of the invention are applicable not only to treatment of urinary and fecal incontinence, but also to the treatment of female sexual dysfunction. Aspects of the invention are also applicable to treatment of male incontinence and male erectile dysfunction.
Owner:NUGYN
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com